These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26607434)

  • 1. Acylation of arginine in goserelin-loaded PLGA microspheres.
    Shirangi M; Hennink WE; Somsen GW; van Nostrum CF
    Eur J Pharm Biopharm; 2016 Feb; 99():18-23. PubMed ID: 26607434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M; Hennink WE; Somsen GW; van Nostrum CF
    Pharm Res; 2015 Sep; 32(9):3044-54. PubMed ID: 25832500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and identification of acylated leuprorelin inside PLGA microspheres.
    Guo N; Zhang Q; Sun Y; Yang H
    Int J Pharm; 2019 Apr; 560():273-281. PubMed ID: 30731258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M; Najafi M; Rijkers DT; Kok RJ; Hennink WE; van Nostrum CF
    Bioconjug Chem; 2016 Mar; 27(3):576-85. PubMed ID: 26726953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.
    Na DH; Youn YS; Lee SD; Son MW; Kim WB; DeLuca PP; Lee KC
    J Control Release; 2003 Oct; 92(3):291-9. PubMed ID: 14568410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC
    J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
    Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide acylation by poly(alpha-hydroxy esters).
    Lucke A; Kiermaier J; Göpferich A
    Pharm Res; 2002 Feb; 19(2):175-81. PubMed ID: 11883645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.
    Zhang Y; Sophocleous AM; Schwendeman SP
    Pharm Res; 2009 Aug; 26(8):1986-94. PubMed ID: 19533307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH; DeLuca PP
    Pharm Res; 2005 May; 22(5):736-42. PubMed ID: 15906168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.
    Ibrahim MA; Ismail A; Fetouh MI; Göpferich A
    J Control Release; 2005 Sep; 106(3):241-52. PubMed ID: 15970349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
    J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of inhibitors of peptide sorption and acylation in PLGA.
    Sophocleous AM; Zhang Y; Schwendeman SP
    J Control Release; 2009 Aug; 137(3):179-84. PubMed ID: 19318114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
    Chu DF; Fu XQ; Liu WH; Liu K; Li YX
    Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres.
    Liang R; Li X; Shi Y; Wang A; Sun K; Liu W; Li Y
    Int J Pharm; 2013 Sep; 454(1):344-53. PubMed ID: 23872225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB; Na DH; Thanoo BC; DeLuca PP
    Int J Pharm; 2005 Jun; 297(1-2):62-72. PubMed ID: 15885939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing acylation of peptides in PLGA microspheres.
    Zhang Y; Schwendeman SP
    J Control Release; 2012 Aug; 162(1):119-26. PubMed ID: 22546683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
    Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
    J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.